BioCryst Pharmaceuticals (BCRX)
|
1.43
-0.08 (-5.30%)
|
|
|
|
BCRX analyst ratings
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
BCRX price and earnings targets
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
Special Offers
BCRX earnings
Date
Actual
Expected
Prev Yr Qtr
2/16/2012
-0.29
-0.29
-0.20
8/4/2011
-0.34
-0.27
-0.23
2/10/2011
-0.20
-0.21
0.35
BioCryst Pharmaceuticals (BCRX) Upgrades
Date
Analyst
Old Rating
New Rating
09/29/2010
Rodman & Renshaw
Market Perform
Market Outperform
BioCryst Pharmaceuticals (BCRX) Downgrades
Date
Analyst
Old Rating
New Rating
09/20/2007
Caris & Company
Above Average
Average
12/11/2006
Caris & Company
Average
Above Average
BioCryst Pharmaceuticals (BCRX) New Coverage
Date
Analyst
Rating
01/29/2010
WBB Securities
Buy
12/21/2009
Morgan Stanley
Equalweight
